Login to Your Account



New Interpretation Of SBIR Rules Puts Squeeze On VC-Backed Firms

By Randall Osborne


Monday, August 18, 2003
As a bridge over troubled financing waters, Small Business Innovation Research grants have an indisputable value, and the advantages are especially well known to start-up biotechnology companies that have availed themselves of SBIRs. (BioWorld Financial Watch)

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription